ORASURE TECHNOLOGIES, INC Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
ORASURE TECHNOLOGIES, INC (OSUR) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 922.00 thousand shares as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2016-05-10
- 2016-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 922.00K shares.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 697.00K shares.
- 2015-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 696.00K shares.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 707.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2016-03-31 | 922.00K shares 10-Q · filed 2016-05-10 |
| 2015-12-31 | 697.00K shares 10-Q · filed 2016-05-10 |
| 2015-03-31 | 696.00K shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 707.00K shares 10-K · filed 2016-03-14 |
| 2014-03-31 | 764.00K shares 10-Q · filed 2014-05-08 |
| 2013-12-31 | 653.00K shares 10-K · filed 2016-03-14 |
| 2013-01-01 | 670.00K shares 10-K · filed 2016-03-14 |
| 2012-12-31 | 670.00K shares 10-K · filed 2015-03-12 |
| 2011-12-31 | 879.00K shares 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |